Table 3.

Expected number of women potentially exposed to unnecessary confirmation tests (EUC), expected cancers detected (CD), expected lives saved (LS), and harm-benefit tradeoffs EUC/CD and EUC/LS per 1,000 women tested with a multi-cancer test for breast, colorectal, liver, lung, pancreatic, and ovary cancers assuming 99% specificity and a common 10% mortality reduction associated with screening for each cancer.

Screening age, y	EUC, n	CD, n	LS, n	EUC/CD	EUC/LS
50	10.4	11.7	0.7	0.9	14.2
60	11.0	22.1	1.9	0.5	5.7
70	11.6	33.1	3.9	0.4	3.0